T1	Participants 103 121	healthy volunteers
T2	Participants 611 662	Healthy male and female volunteers aged 18-75 years
T3	Participants 678 904	All volunteers received ASA 81 mg once daily for 5 days prior to the study (pre-screen). Subjects were eligible for inclusion if they had aspirin reactivity units (ARU, as measured by the VerifyNow ASA assay) of <550 on Day 6.
T4	Participants 1450 1500	29 volunteers (19 aged â‰¥50 years; 8 women; 21 men)
T5	Participants 1561 1622	All volunteers on both treatments achieved ARU <550 at Day 6.
